Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Banco Bradesco S.A is a banks-regional business based in the US. Banco Bradesco S-A shares (BBD) are listed on the NYSE and all prices are listed in US Dollars. Banco Bradesco S-A employs 87,362 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.60|
|52-week range||$2.98 - $5.57|
|50-day moving average||$3.95|
|200-day moving average||$4.55|
|Wall St. target price||$5.83|
|Dividend yield||$1.002 (27.23%)|
|Earnings per share (TTM)||$0.39|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-7.93%|
|1 month (2021-09-24)||-5.26%|
|3 months (2021-07-23)||-21.23%|
|6 months (2021-04-23)||-15.09%|
|1 year (2020-10-23)||-1.00%|
|2 years (2019-10-23)||-49.93%|
|3 years (2018-10-23)||7.4298|
|5 years (2016-10-21)||7.6784|
Valuing Banco Bradesco S-A stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Banco Bradesco S-A's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Banco Bradesco S-A's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Banco Bradesco S-A shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Banco Bradesco S-A's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3793. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Banco Bradesco S-A's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$91.3 billion|
|Operating margin TTM||40.19%|
|Gross profit TTM||$61.3 billion|
|Return on assets TTM||1.36%|
|Return on equity TTM||15.04%|
|Market capitalisation||$37.9 billion|
TTM: trailing 12 months
There are currently 33.3 million Banco Bradesco S-A shares held short by investors – that's known as Banco Bradesco S-A's "short interest". This figure is 15.4% up from 28.8 million last month.
There are a few different ways that this level of interest in shorting Banco Bradesco S-A shares can be evaluated.
Banco Bradesco S-A's "short interest ratio" (SIR) is the quantity of Banco Bradesco S-A shares currently shorted divided by the average quantity of Banco Bradesco S-A shares traded daily (recently around 34.0 million). Banco Bradesco S-A's SIR currently stands at 0.98. In other words for every 100,000 Banco Bradesco S-A shares traded daily on the market, roughly 980 shares are currently held short.
However Banco Bradesco S-A's short interest can also be evaluated against the total number of Banco Bradesco S-A shares, or, against the total number of tradable Banco Bradesco S-A shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Banco Bradesco S-A's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Banco Bradesco S-A shares in existence, roughly 0 shares are currently held short) or 0.0048% of the tradable shares (for every 100,000 tradable Banco Bradesco S-A shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Banco Bradesco S-A.
Find out more about how you can short Banco Bradesco S-A stock.
Dividend payout ratio: 24.73% of net profits
Recently Banco Bradesco S-A has paid out, on average, around 24.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Banco Bradesco S-A shareholders could enjoy a 2.77% return on their shares, in the form of dividend payments. In Banco Bradesco S-A's case, that would currently equate to about $1.002 per share.
While Banco Bradesco S-A's payout ratio might seem low, this can signify that Banco Bradesco S-A is investing more in its future growth.
Banco Bradesco S-A's most recent dividend payout was on 7 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 3 October 2021 (the "ex-dividend date").
Banco Bradesco S-A's shares were split on a 6:5 basis on 31 March 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 6 shares. This wouldn't directly have changed the overall worth of your Banco Bradesco S-A shares – just the quantity. However, indirectly, the new 16.7% lower share price could have impacted the market appetite for Banco Bradesco S-A shares which in turn could have impacted Banco Bradesco S-A's share price.
Over the last 12 months, Banco Bradesco S-A's shares have ranged in value from as little as $2.9763 up to $5.5652. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Banco Bradesco S-A's is 1.1922. This would suggest that Banco Bradesco S-A's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Banco Bradesco S. A. , together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through Banking and Insurance segments. It provides demand and time deposits, savings deposits, mutual funds, and a range of loans and advances, including overdrafts, credit cards, and loans with repayments in installments; and fund management and treasury services, foreign exchange services, corporate finance and investment banking services, and hedge and finance services, including working capital financing. The company offers leasing, investment and private banking, brokerage, and consortium management services, as well as real estate products, pension plans, and capitalization bonds. It also provides auto, health, life, and accident and non-life insurance products.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.